Overview

Pharmacokinetic Interaction Between TRUVADA™ and BILR 355 BS Plus Ritonavir in Healthy Volunteers

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Study to determine the pharmacokinetic effect of BILR 355 + ritonavir® on TRUVADA and TRUVADA on BILR 355
Phase:
Phase 1
Details
Lead Sponsor:
Boehringer Ingelheim
Treatments:
Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination
Ritonavir